Grant of options

AI SummaryClose X

Fusion Antibodies plc has granted 2,910,000 share options to executive directors and employees under its share option scheme, with an exercise price of 10.30 pence per option, reflecting the closing mid-market price on July 17, 2026. These options will vest equally over three years and can be exercised for ten years. Specifically, the CEO received 600,000 options and the CSO received 400,000 options. Following this grant, the company has a total of 6,086,600 options outstanding, representing 4.86% of its issued share capital.

Disclaimer*

UK 100

Latest directors dealings